3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
88
Colonic Neoplasms
30
Colonic Polyps
20
Adenoma
11
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Disease
5
Rectal Neoplasms
4
Polyps
4
Neoplasms
4
Gastrointestinal Neoplasms
4
Stomach Neoplasms
2
Peptic Ulcer
2
Pancreatic Neoplasms
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Anus Neoplasms
2
Adenomatous Polyps
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Diseases
1
Patient Satisfaction
1
Pancreatitis, Chronic
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Interventions
Gemcitabine
3
pembrolizumab
2
napabucasin
2
entinostat
2
Taxes
2
Sunitinib
2
Sorafenib
2
130-nm albumin-bound paclitaxel
2
trametinib
1
siltuximab
1
repotrectinib
1
pralsetinib
1
lutetium Lu 177 dotatate
1
linifanib
1
durvalumab
1
dabrafenib
1
copper dotatate CU-64
1
cobimetinib
1
capmatinib
1
atezolizumab
1
Vemurafenib
1
Pemetrexed
1
Paclitaxel
1
Lutetium-177
1
Lutetium
1
Leucovorin
1
Irinotecan
1
Immunotherapy
1
HhAntag691
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Colonoscopy
×
Gastrointestinal
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled